Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

NCT02992418 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

688

Enrollment

INDUSTRY

Sponsor class

Stopped No answer received from the Philippines Food and Drug Administration on protocol amendment issued due to IDMC recommendations. CYD vaccine 3rd dose not given.

Conditions

Dengue Fever
Dengue Hemorrhagic Fever

Interventions

BIOLOGICAL: CYD Dengue Vaccine
BIOLOGICAL: Tdap: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine adsorbed
BIOLOGICAL: Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

Sponsor

Sanofi Pasteur, a Sanofi Company